[Drug treatment of Alzheimer's dementia : Status quo and perspectives]. / Pharmakologische Therapie der Alzheimer-Demenz : Aktueller Stand und Perspektiven.
Internist (Berl)
; 60(7): 761-768, 2019 Jul.
Article
en De
| MEDLINE
| ID: mdl-31139854
Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system. AD is characterized by progressive impairments of memory as well as other cognitive functions and an increasing loss of autonomy in everyday life. This review article provides an overview of the current state-of-the-art (symptomatic) pharmacological treatment of Alzheimer's disease, specifics in the context of concomitant neuropsychiatric symptoms in multimorbid patients, and drugs currently under development that have a potentially causal (disease modifying) effect are also mentioned.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Memantina
/
Inhibidores de la Colinesterasa
/
Enfermedad de Alzheimer
Límite:
Humans
Idioma:
De
Revista:
Internist (Berl)
Año:
2019
Tipo del documento:
Article
Pais de publicación:
Alemania